Search

Search Results
Results 261 - 270 of 274 for Acute pancreatitis
  • Drug - 14 Nov 2024
    Consumer Medicine Information (CMI) about Lonsurf intended for persons living in Australia.
  • Drug - 24 Sep 2024
    Consumer Medicine Information (CMI) about Jardiamet (empagliflozin / metformin hydrochloride) intended for persons living in Australia.
  • Drug - 16 Jul 2024
    Consumer Medicine Information (CMI) about Gliclazide MR Viatris (containing gliclazide) intended for persons living in Australia.
  • Drug - 1 Jul 2024
    Consumer Medicine Information (CMI) about Trajentamet (linagliptin / metformin hydrochloride) intended for persons living in Australia.
  • Drug - 30 May 2024
    Consumer Medicine Information (CMI) about Trulicity intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Nextstellis intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.